X0306 4 2019-11-04 0 0001673772 RAPT Therapeutics, Inc. RAPT 0001182464 GOEDDEL DAVID V C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 1 0 1 0 Common Stock 2019-11-04 4 C 0 2463659 A 2463659 I By The Column Group II, LP Common Stock 2019-11-04 4 C 0 1166666 A 3630325 I By The Column Group II, LP Common Stock 2019-11-04 4 C 0 727008 A 4357333 I By The Column Group II, LP Common Stock 2019-11-04 4 P 0 625000 12.00 A 4982333 I By The Column Group II, LP Common Stock 2019-11-04 4 C 0 1454016 A 1454016 I By Ponoi Capital, LP Common Stock 2019-11-04 4 C 0 145401 A 1599417 I By Ponoi Capital, LP Common Stock 2019-11-04 4 C 0 145401 A 145401 I By Ponoi Capital II, LP Common Stock 50000 I By The Column Group II Management, LP Series A Preferred Stock 2019-11-04 4 C 0 14781963 0.00 D Common Stock 2463659 0 I By The Column Group II, LP Series B Preferred Stock 2019-11-04 4 C 0 7000000 0.00 D Common Stock 1166666 0 I By The Column Group II, LP Series C Preferred Stock 2019-11-04 4 C 0 4362050 0.00 D Common Stock 727008 0 I By The Column Group II, LP Series C Preferred Stock 2019-11-04 4 C 0 8724100 0.00 D Common Stock 1454016 0 I By Ponoi Capital, LP Series C-2 Preferred Stock 2019-11-04 4 C 0 872410 0.00 D Common Stock 145401 0 I By Ponoi Capital, LP Series C-2 Preferred Stock 2019-11-04 4 C 0 872410 0.00 D Common Stock 145401 0 I By Ponoi Capital II, LP At the closing of the Issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, and Series C-2 Preferred Stock of the Issuer automatically converted into approximately 0.166 shares of the Issuer's common stock (on an adjusted basis, after giving effect to the 1-for-6 reverse stock split of the common stock effected by the Issuer on July 19, 2019) for no additional consideration. Shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series C-2 Preferred Stock have no expiration date. David Goeddel is a managing partner of The Column Group II GP, LP, which is the general partner of The Column Group II, LP. Dr. Goeddel is also a managing partner of The Column Group II Management, LP. Dr. Goeddel is also a managing partner of Ponoi Management, LLC, general partner of Ponoi Capital, LP, and a managing partner of Ponoi II Management, LLC, general partner of Ponoi Capital II, LP. Dr. Goeddel may be deemed to share voting and investment power with respect to the shares reported herein and disclaims beneficial ownership of the shares except to the extent of his pecuniary interests therein. These shares are held directly by The Column Group II, LP. These shares are held directly by Ponoi Capital, LP. These shares are held directly by Ponoi Capital II, LP. These shares are held directly by The Column Group II Management, LP. /s/ Karen C. Lam, attorney-in-fact for David V. Goeddel 2019-11-04